Krazati Patient Assistance Program

(adagrasib)

Key Takeaways

  1. Krazati® (adagrasib) is a prescription targeted cancer therapy used to treat certain adults with KRAS G12C-mutated non-small cell lung cancer (NSCLC) and colorectal cancer (CRC).
  2. Krazati is a KRAS G12C inhibitor that blocks a specific genetic mutation responsible for driving the growth of certain cancers.
  3. Patients must have confirmation of a KRAS G12C mutation using an FDA-approved companion diagnostic test before beginning treatment.
  4. Prescription Hope may help eligible individuals access manufacturer-sponsored patient assistance programs that can make Krazati more affordable.

 

Introduction

Advances in precision medicine have transformed cancer treatment by allowing therapies to target specific genetic mutations that help tumors grow. One of these mutations, known as KRAS G12C, occurs in a subset of non-small cell lung cancers and colorectal cancers. For patients whose tumors carry this mutation, targeted therapies like Krazati offer an option designed specifically to block the abnormal protein driving cancer growth.

Krazati is an oral targeted therapy approved for certain adults with previously treated KRAS G12C-mutated non-small cell lung cancer and, when used in combination with cetuximab, for certain adults with previously treated KRAS G12C-mutated colorectal cancer. By selectively inhibiting the abnormal KRAS G12C protein, Krazati helps slow tumor growth and may shrink tumors in eligible patients.

Because Krazati is a specialty oncology medication, treatment costs can be substantial without insurance or financial assistance. Many patients searching for the Krazati patient assistance program are looking for ways to reduce out-of-pocket expenses while continuing treatment.

Accessing patient assistance programs through Prescription Hope may help eligible patients obtain Krazati at a more affordable cost.

What Is the Krazati Patient Assistance Program?

Understanding Krazati Prescription Assistance

Unfortunately, brand-name medications can retail at much higher costs than average Americans can afford. When insurance coverage or assistance is inadequate, patients often choose to delay or even stop treatment.

To help alleviate the financial burden, manufacturers often offer patient assistance programs, which provide specific brand-name medications at affordable rates.

However, many of these programs have included complex application processes that require extensive documentation, communication, and forms to qualify.

Thankfully, Prescription Hope offers a solution.

How Expert Advocates Help Make Krazati More Affordable

Personalized Medication Assistance

Prescription Hope’s cancer medication support services offer qualified patients access to brand-name medications by providing application help for medications like Krazati. Our team of patient advocates manages the process from start to finish, including form completion, document and signature collection, issue resolution, and coordination with healthcare providers and the manufacturers.

Ongoing Patient Support

Not only that, but our team members provide treatment continuity long after you qualify. Our services include long-term medication assistance.

This means our patient advocates support prescription refill scheduling, document updates, program monitoring, and yearly updates.

Krazati Price Comparison

vs

Prescription Hope logo

Estimated Retail Price*

$22,517.36

30-Day Supply

Prescription Hope Price

$70

Per Month, NO Matter The Retail Price

*Source: Drugs.com

Navigating Cancer Treatment Costs

Considering the retail costs of medications like Krazati can be unaffordable for many Americans, our colorectal cancer medication assistance services may be the lifeline patients need to finally afford their medication costs.

Our service rate of $70.00 per month, per medication includes all services we offer, and never includes hidden fees, variable pricing, or even medication costs.

And if you don’t qualify, then you pay nothing!

Krazati Patient Assistance Eligibility

General Eligibility Requirements

While each program maintains its own specific criteria for qualification, every program uses several general categories to determine medication assistance eligibility. Some of those categories include:

Income: Every program uses an income threshold to determine qualification. Each program differs in the yearly income minimum and maximum used.

Insurance: All programs determine a patient’s qualification with insurance coverage status. However, some require a patient to have no insurance while others allow patients to have some form of insurance.

Prescription: Programs require qualified patients to have a valid prescription for the brand-name medication they wish to apply for.

U.S. Residency: All programs require a qualified patient to have legal U.S. residency.

Simple Enrollment With Expert Support

Getting Started With Enrollment

Ready to get started with your patient assistance registration? Looking to enroll in Krazati assistance?

To do so through Prescription Hope, it only takes 6 simple steps:

  1. Submit Information: Our online enrollment form can be completed in a matter of minutes.
  2. Advocate Contact: After we receive your completed form, a patient advocate will reach out within 1-2 business days.
  3. Document Collection: Following prequalification, our team members will collect all documents needed for your application.
  4. Provider Coordination: We also coordinate with your healthcare provider to get all needed signatures.
  5. Program Submission: Once we have everything in order, we submit your application and continue to coordinate with the manufacturer.
  6. Medication Delivery: After approval, qualified patients typically receive their medication within 2 weeks. All medications ship directly from the manufacturer to your house or doctor’s office.

Please note: Prescription Hope is not a pharmacy or manufacturer, and therefore does not handle medications at any time.

Understanding Krazati

How Krazati Works

Some cancers contain a mutation called KRAS G12C, which causes cancer cells to grow and divide uncontrollably.

Krazati works by selectively binding to the abnormal KRAS G12C protein and locking it into its inactive state. This blocks signals that promote cancer cell growth and survival, helping slow tumor growth and, in some patients, causing cancer cells to die.

Because it targets a specific genetic mutation, Krazati is considered a precision medicine.

What Conditions Does Krazati Treat?

Krazati is FDA-approved for the treatment of adults with certain cancers that have a KRAS G12C mutation, as identified by an FDA-approved companion diagnostic test.

Non-Small Cell Lung Cancer (NSCLC)

Krazati is approved for adults with:

  • Locally advanced or metastatic non-small cell lung cancer (NSCLC)
  • Tumors with a confirmed KRAS G12C mutation
  • Disease that has progressed after at least one prior systemic therapy

Colorectal Cancer (CRC)

Krazati is approved in combination with cetuximab for adults with:

  • Locally advanced or metastatic colorectal cancer (CRC)
  • KRAS G12C-mutated tumors confirmed by an FDA-approved companion diagnostic
  • Previous treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy

Patients must undergo molecular testing to confirm the presence of a KRAS G12C mutation before starting treatment.

Benefits of Treatment

For eligible patients with KRAS G12C-mutated cancers, Krazati may:

  • Slow cancer growth
  • Shrink tumors in some patients
  • Delay disease progression
  • Provide a treatment option after previous therapies have stopped working
  • Target cancer cells with a specific genetic mutation while limiting effects on normal cells
  • Improve disease control when combined with cetuximab for eligible patients with colorectal cancer

Individual treatment responses vary depending on the cancer type, extent of disease, and overall health.

Important Safety Information and Side Effects

Krazati does not carry an FDA Boxed Warning.

The most commonly reported side effects include:

  • Diarrhea
  • Nausea
  • Vomiting
  • Fatigue
  • Increased liver enzymes
  • Decreased appetite
  • Constipation
  • Abdominal pain
  • Swelling (edema)
  • Shortness of breath
  • Muscle or joint pain
  • Cough
  • Dizziness

Common laboratory abnormalities include:

Patients should notify their healthcare provider if side effects become severe or persistent.

Patients should discuss the following important risks with their healthcare provider before and during treatment:

  • Hepatotoxicity (liver injury)
  • Interstitial lung disease (ILD) or pneumonitis
  • Gastrointestinal toxicity, including severe diarrhea, nausea, and vomiting
  • QTc interval prolongation, which may lead to serious heart rhythm abnormalities
  • Serious adverse reactions resulting from interactions with CYP3A substrates and other affected drug transporters
  • Embryo-fetal toxicity, which may cause harm to an unborn baby

Healthcare providers typically monitor:

  • Liver function tests
  • Electrocardiograms (ECGs)
  • Electrolytes, including potassium and magnesium
  • Pulmonary symptoms throughout treatment

Krazati may cause fetal harm during pregnancy. Females of reproductive potential should use effective contraception during treatment and for the recommended period after the final dose. Male patients with partners who can become pregnant should discuss contraception recommendations with their healthcare provider.

Breastfeeding is not recommended during treatment and for one week after the final dose because of the potential for serious adverse reactions in a breastfed child.

Krazati may interact with:

  • Strong CYP3A inhibitors
  • Strong CYP3A inducers
  • Sensitive CYP3A substrates
  • P-glycoprotein (P-gp) substrates
  • Medications that prolong the QT interval
  • Proton pump inhibitors (PPIs)
  • H2-receptor antagonists
  • Antacids (follow FDA labeling regarding administration timing)

Patients should provide a complete list of prescription medications, over-the-counter medicines, vitamins, and herbal supplements before starting therapy.

Krazati is taken orally, typically twice daily, and may be taken with or without food. Tablets should be swallowed whole and should not be crushed, split, or chewed. If vomiting occurs after taking a dose, patients should not take an additional dose and should resume their regular dosing schedule with the next scheduled dose. Treatment generally continues until disease progression or unacceptable toxicity occurs.

Healthcare providers routinely monitor liver function, electrolyte levels, electrocardiograms, pulmonary symptoms, and gastrointestinal side effects throughout therapy.

Access to Multiple Medications

Support Beyond Krazati

Oftentimes, patients needing cancer medication assistance also need assistance with their other medications. To help complement your lung cancer medication support, Prescription Hope can also provide access to multiple medication assistance programs at once.

With a list of hundreds of brand-name medications available for access, Prescription Hope can support your medication access journey for a simple $70.00 per month, per medication. No matter how many meds you qualify for through us.

Why Choose Prescription Hope for Krazati Assistance

Patient-Focused Medication Support

Prescription Hope has provided patient-centered prescription help to patients across America for 20 years. Our team of patient advocates is Florida-based and ready to support you with your Krazati assistance journey.

Simplified Access to Specialty Medications

Our service rate of $70.00 per month, per medication covers your prescription assistance help process from start to finish.

We manage form completion, document and signature collection, coordinating with healthcare providers and manufacturers, and more.

Ongoing Prescription Assistance

Plus, our long-term medication support gives qualified patients affordable Krazati access for as long as they are a patient with us. We manage the administrative tasks associated with patient assistance programs. Those tasks include document and information updates, issue resolution, program monitoring, yearly renewals, and even refill scheduling.

If you’re looking for Krazati prescription assistance, then be sure to enroll through Prescription Hope and see how we can help you save.

 

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!